Inhibikase Therapeutics I... (IKT)
2.38
0.08 (3.48%)
At close: Mar 03, 2025, 12:03 PM
Inhibikase Therapeutics Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | -0.36 | -0.7 | -1.81 | -24.1 | -17.78 | -36.86 | -234.31 | -122.77 |
| PEG Ratio | 0.02 | 0.06 | -0.01 | 0.50 | -0.17 | -0.07 | 4.89 | n/a |
| PS Ratio | 26.00 | 102.12 | 8.63 | 99.29 | 91.01 | 19.63 | 49.58 | 79.79 |
| PB Ratio | 0.62 | 0.60 | 0.70 | 7.09 | -22.76 | -101.98 | -70.91 | -57.11 |
| P/FCF Ratio | -0.37 | -0.72 | -1.87 | -61.41 | -302.04 | 110.96 | -808.41 | -2.61K |
| P/OCF Ratio | -0.37 | -0.73 | -1.87 | -61.41 | -302.04 | 110.96 | -808.41 | -2.61K |
| OCF/S Ratio | -69.42 | -140.56 | -4.61 | -1.62 | -0.3 | 0.18 | -0.06 | -0.03 |
| Debt / Equity Ratio | 0.06 | 0.02 | 0.01 | 0.03 | -0.08 | -0.3 | -0.32 | -0.24 |
| Quick Ratio | 4.13 | 6.29 | 10.45 | 3.13 | 0.01 | 0.35 | 0.11 | 0.05 |
| Current Ratio | 4.13 | 6.59 | 10.47 | 3.13 | 0.01 | 0.35 | 0.11 | 0.05 |
| Asset Turnover | 0.02 | 0.00 | 0.07 | 0.05 | 29.35 | 1.42 | 7.23 | 5.94 |
| Interest Coverage | n/a | -243.49 | -741.16 | -95.86 | -229.44 | -69.96 | n/a | n/a |
| Return on Equity (ROE) | -1.73 | -0.85 | -0.39 | -0.29 | 1.28 | 2.77 | 0.30 | 0.47 |
| Return on Assets (ROA) | -1.31 | -0.72 | -0.35 | -0.19 | -150.25 | -0.76 | -1.53 | -3.86 |
| Return on Capital (ROIC) | -1.82 | -0.85 | -0.38 | -0.28 | 1.35 | 2.73 | 0.28 | 0.45 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -5.13K% | 94.55% | -266.35% | -27.97% | -127.36% | 9.75% | 14.81% | 12.51% |
| Net Profit Margin | -7.3K% | -14.51K% | -477.52% | -411.94% | -511.95% | -53.27% | -21.16% | -64.99% |
| Pretax Profit Margin | -7.3K% | -14.63K% | -476.88% | -407.73% | -509.73% | -53.27% | -21.16% | -64.99% |
| Operating Profit Margin | -7.71K% | -14.69K% | -476.23% | -403.52% | -507.52% | -52.52% | -19.66% | -63.4% |
| FCF Margin | -6.95K% | -14.25K% | -461.11% | -161.69% | -30.13% | 17.69% | -6.13% | -3.06% |
| EBITDA Margin | -7.64K% | -14.68K% | -476.23% | -403.52% | -507.52% | n/a | n/a | n/a |